Senior insider sale
General Counsel at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.48M
46.17K shares
HANSON KRISTOPHER plans to sell 46.17K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/18/2025 | Restricted Stock Unit Grant N/A | 27.48K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 3.01K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 853.00 | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 1.67K | — |
| Total | 33.02K | ||
Completed
Units to sell
13.92K
Market value
$419.2K
Units to sell
13.92K
Market value
$388.1K
Units to sell
298.00
Market value
$8.2K
Units to sell
1.53K
Market value
$41.0K
Planned — Approximate Date
Units to sell
16.51K
Market value
$625.8K
Units
46.17K
Value
$1.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/11/2026 | 13.92K | $419.2K | — | Completed |
5/4/2026 | 13.92K | $388.1K | — | Completed |
4/16/2026 | 298.00 | $8.2K | — | Completed |
4/15/2026 | 1.53K | $41.0K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 16.51K | $625.8K | Nasdaq | Planned |
| Total | 46.17K | $1.48M | ||